December 10, 1998

New Steriods Library

Steriod library containing about 200 steriod compounds has been launched from R & D team in SynChem, Inc. Steriod Library consists of analogues with quantities ranging from 10 to 20 mg each. Due to the rich structural elements rareness, such libraries are believed to have wide range of applications in the drug discovery.

November 20, 1998

New Products launched, Box and PyBox

SynChem, Inc., a research company specializing in asymmetric organic synthesis and custom synthesis, has launched new series of chiral ligands called Bis (oxazoline) or Box and PyBox. Using new technology the production team in SynChem, Inc. is able to produce these products in multi-kilograms scale with high quality. These ligands have been widely used in catalytic asymmetric syntheses in organic transformation, such as Diels-Alder reaction. See more in Technology Section in our website.

August 30, 1998

Scientists from SynChem jointed ACS Meeting in Boston

Scientists at SynChem, Inc. reported a large scale preparation of BINOL monomethyl ether at the 216th ACS National Meeting in Boston. The reaction they reported was conducted in 81% yield with no loss of enantiomeric purity. The methodology was to also useful in the preparation of the ethyl, isopropyl, n-butyl, benzyl, allyl, and 2-naphthylmethyl ethers. Scientists at SynChem shared their research results with over 200 chemists in their poster section.

April 30, 1998

SynChem Awarded Third Phase I SBIR Grant to Study New Catalytic Asymmetric Synthesis of b-Amino Acids

SynChem, Inc., a research company in Chicago today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant of totally $100,000 from the National Institute of General Medical Sciences. The research will focus on the new method development for the synthesis of b-amino acids, which are very important building blocks for anticancer and antiviral drug candidates, such as Taxol. This grant will help SynChem broaden its own technology platform based on the new chiral technology, and provide the opportunity to discover new chiral ligand in the asymmetric synthesis chemistry.

January 30, 1998

SynChem Awarded Second Phase I SBIR Grant to Develop New Asymmetric Synthesis of Unnatural Amino Acids

SynChem, Inc, a research company in Chicago, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant of totally $100,000 from the National Institute of General Medical Sciences. The grant will enable SynChem to continue its effort on the developing new economically and environmentally friendly method to synthesize unnatural amino acids, which are important building blocks for peptides drugs.

October 30, 1998

SynChem Awarded Phase I SBIR Grant to Develop New Catalytic Synthesis of Unnatural Amino Acids

SynChem, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant of totally $95,000 from the National Cancer Institute and National Institute of Allergy and Infectious Diseases. The research grant title is catalytic synthesis of unnatural amino acids. This grant will enable SynChem to develop new asymmetric synthetic method of unnatural amino acids, which are important building block to peptide drugs for anticancer and antiviral drug candidates.